- Sulphur Ointment
- Benzyl Benzoate Lotion
- Lindane Lotion
- Crotamiton Cream
- Permethrin Cream
- Others
Scabies Treatment Market size was valued at USD 225.8 million in 2022 and is expected to grow at 5.2% CAGR from 2023 to 2029 owing to the increased infestation of Scabies cases in hot, tropical countries and in areas of high population density. Scabies treatment includes a range of medications used to treat Scabies; a contagious itchy skin rash caused by a tiny burrowing mite called Sarcoptes scabies mite. Poverty, overcrowding, malnutrition, and lack of local expertise to recognize scabies leading to delayed diagnosis in underdeveloped and developing countries are major driving factors market. According to WHO 2023, 200 million people worldwide suffer from scabies at any one time, and more than 400 million people cumulatively every year. Moreover, rapid advancements in the healthcare and medical sector, high adoption of the latest tools and techniques, and growing funds by several public and private sectors have increased the opportunities for the advancement of the scabies treatment market. For instance, serology test and enzyme-linked immunosorbent assay (ELISA) in the last decade has proven to be highly sensitive (100%) and specific (97%) in identifying infected animals.
Furthermore, the shortage of drugs, vaccines, and medical supplies in hospitals is expected to offer industry players profitable growth opportunities in the coming years. Rising personal disposable income is another indirect element that will result in profitable market expansion potential. But, the abundance of homecare treatments and the unfavourable reimbursement environment in developing and underdeveloped economies along with high research and development expenses are expected to the growth of the scabies treatment market. However, the rising demand for targeted therapies, an increase in R&D activities for the creation of novel drugs and treatments, increased governmental awareness programs, a high prevalence of skin disorders, the disease's high contagiousness, and increased investments for the construction of healthcare infrastructure are some factors leading to the profitable growth of the market and is expected to flourish in the forecasted years.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Improper hygienic conditions and environmental factors are the key factor to increase the number of person affected to scabies. Moreover, low cost of drugs, increase in R&D for the innovation of newer drugs, rapid escalation of global population with poor hygienic, and increase in healthcare expenditure are anticipated to fuel the scabies treatment market. Moreover, homecare remedies for the scabies treatment and limited number of advanced therapeutics are expected to restrain the growth of scabies treatment market.
The scabies treatment market is projected to expand at a CAGR of 5.1% during the forecast period
Merck & Co. Inc. (U.S.), Renaissance Pharma, Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), GlaxoSmithKline plc (U.K.), Unichem Laboratories Ltd. (India), Zydus Cadila (India), Prestium Pharma, Inc. (U.S.)
North America is the fastest-growing region for the home infusion therapy devices market
1. Executive Summary |
2. Global Scabies Treatment Market Introduction |
2.1.Global Scabies Treatment Market - Taxonomy |
2.2.Global Scabies Treatment Market - Definitions |
2.2.1.Drug Type |
2.2.2.Route of Administration |
2.2.3.Distribution Channel |
2.2.4.Region |
3. Global Scabies Treatment Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Scabies Treatment Market Analysis, 2018-2022 and Forecast 2023-2029 |
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Scabies Treatment Market By Drug Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
5.1. Sulphur Ointment |
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Benzyl Benzoate Lotion |
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Lindane Lotion |
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Crotamiton Cream |
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Permethrin Cream |
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Others |
5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
6. Global Scabies Treatment Market By Route of Administration, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
6.1. Oral |
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Topical |
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7. Global Scabies Treatment Market By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
7.1. Hospital Pharmacies |
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Retail Pharmacies |
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Online Pharmacies |
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8. Global Scabies Treatment Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. North America Scabies Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
9.1. Drug Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Sulphur Ointment |
9.1.2.Benzyl Benzoate Lotion |
9.1.3.Lindane Lotion |
9.1.4.Crotamiton Cream |
9.1.5.Permethrin Cream |
9.1.6.Others |
9.2. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Oral |
9.2.2.Topical |
9.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospital Pharmacies |
9.3.2.Retail Pharmacies |
9.3.3.Online Pharmacies |
9.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10. Europe Scabies Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
10.1. Drug Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Sulphur Ointment |
10.1.2.Benzyl Benzoate Lotion |
10.1.3.Lindane Lotion |
10.1.4.Crotamiton Cream |
10.1.5.Permethrin Cream |
10.1.6.Others |
10.2. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Oral |
10.2.2.Topical |
10.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospital Pharmacies |
10.3.2.Retail Pharmacies |
10.3.3.Online Pharmacies |
10.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11. Asia Pacific (APAC) Scabies Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
11.1. Drug Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Sulphur Ointment |
11.1.2.Benzyl Benzoate Lotion |
11.1.3.Lindane Lotion |
11.1.4.Crotamiton Cream |
11.1.5.Permethrin Cream |
11.1.6.Others |
11.2. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Oral |
11.2.2.Topical |
11.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospital Pharmacies |
11.3.2.Retail Pharmacies |
11.3.3.Online Pharmacies |
11.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12. Middle East and Africa (MEA) Scabies Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
12.1. Drug Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Sulphur Ointment |
12.1.2.Benzyl Benzoate Lotion |
12.1.3.Lindane Lotion |
12.1.4.Crotamiton Cream |
12.1.5.Permethrin Cream |
12.1.6.Others |
12.2. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Oral |
12.2.2.Topical |
12.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospital Pharmacies |
12.3.2.Retail Pharmacies |
12.3.3.Online Pharmacies |
12.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13. Latin America Scabies Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
13.1. Drug Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Sulphur Ointment |
13.1.2.Benzyl Benzoate Lotion |
13.1.3.Lindane Lotion |
13.1.4.Crotamiton Cream |
13.1.5.Permethrin Cream |
13.1.6.Others |
13.2. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Oral |
13.2.2.Topical |
13.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospital Pharmacies |
13.3.2.Retail Pharmacies |
13.3.3.Online Pharmacies |
13.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1. Merck & Co. Inc. (U.S.) |
14.2.2. Renaissance Pharma, Inc. (U.S.) |
14.2.3. Sun Pharmaceutical Industries Ltd. (India) |
14.2.4. GlaxoSmithKline plc (U.K.) |
14.2.5. Unichem Laboratories Ltd. (India) |
14.2.6. Zydus Cadila (India) |
14.2.7. Prestium Pharma, Inc. (U.S.) |
15. Research Methodology |
16. Appendix and Abbreviations |